"Viking Therapeutics' Weight-Loss Drug Sparks Stock Surge"
Viking Therapeutics' shares more than doubled after the biopharmaceutical company announced "statistically significant" results from a weight-loss trial. The positive outcome of the trial led to a surge in the company's stock, reflecting investor optimism about the potential of its treatment.